CD163+, CD204+ and CD206+ cells accounted for approximately 40–45% of alveolar macrophages in the lungs of non-smokers and smokers, whereas they accounted for 80–70% of alveolar macrophages in patients with stage III/IV COPD. Here, MRC1 is linked to chronic obstructive pulmonary disease.